Study does not support routine HPV quadrivalent vaccination to protect against anal cancer in older people living with HIV
‘On-demand’ rectal microbicide gel has reasonable tolerability and acceptability – daily less so
Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people
Option B+ has enabled Malawi to make significant progress towards 90-90-90
Condom use in French PrEP trial: half only used PrEP, a quarter used condoms and PrEP, one in six used neither
Empirical TB treatment comes up short again
Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low
Large-scale household TB screening shows feasibility in PopART trial
Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016
